First Merchants: Q2 Earnings Insights

  First Merchants (NASDAQ:FRME) reported its Q2 earnings results on Tuesday, July 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

 

First Merchants (NASDAQ:FRME) reported its Q2 earnings results on Tuesday, July 26, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

First Merchants beat estimated earnings by 24.69%, reporting an EPS of $1.01 versus an estimate of $0.81.

Revenue was up $21.79 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 3.39% drop in the share price the next day.

Here’s a look at First Merchants’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.87 0.93 0.91 0.92
EPS Actual 0.88 0.89 0.98 1.03
Revenue Estimate 133.52M 136.45M 133.91M 131.71M
Revenue Actual 128.18M 127.12M 133.22M 135.15M

To track all earnings releases for First Merchants visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

TG Therapeutics Announces FDA Approval Of BRIUMVI; Company To Host Conference Call On Thursday, December 29, 2022 At 8:30 Am ET

BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a one-hour infusion twice-a-year following the starting dose U.S. Commercial launch expected Q1 2023 Company to host conference call on Thursday, December 29, 2022 at 8:30 AM ET

TGTX